Similar articles for PMID: 19443597

Year	Number of Results
2005	1
2006	3
2007	2
2008	10
2009	9
2010	10
2011	9
2012	14
2013	14
2014	17
2015	9
2016	11
2017	9
2018	10
2019	8
2020	8
2021	12
2022	10
2023	1
2024	1

1

Comparison of 18F-FDG and PiB PET in cognitive impairment.

Lowe VJ, Kemp BJ, Jack CR Jr, Senjem M, Weigand S, Shiung M, Smith G, Knopman D, Boeve B, Mullan B, Petersen RC. Lowe VJ, et al. J Nucl Med. 2009 Jun;50(6):878-86. doi: 10.2967/jnumed.108.058529. Epub 2009 May 14. J Nucl Med. 2009. PMID: 19443597 Free PMC article.

2

Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.

Förster S, Yousefi BH, Wester HJ, Klupp E, Rominger A, Förstl H, Kurz A, Grimmer T, Drzezga A. Förster S, et al. Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1927-36. doi: 10.1007/s00259-012-2230-9. Epub 2012 Aug 28. Eur J Nucl Med Mol Imaging. 2012. PMID: 22926714

3

Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.

Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, DeSanti S, Kemppainen N, Någren K, Kim BC, Tsui W, de Leon MJ. Li Y, et al. Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2169-81. doi: 10.1007/s00259-008-0833-y. Epub 2008 Jun 20. Eur J Nucl Med Mol Imaging. 2008. PMID: 18566819 Free PMC article.

4

Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease.

Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Schöll M, Almkvist O, Wall A, Långström B, Nordberg A. Rodriguez-Vieitez E, et al. J Nucl Med. 2016 Jul;57(7):1071-7. doi: 10.2967/jnumed.115.168732. Epub 2016 Feb 16. J Nucl Med. 2016. PMID: 26912447 Free article.

5

Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment.

Wang Y, Lou F, Li Y, Liu F, Wang Y, Cai L, Gordon ML, Zhang Y, Zhang N. Wang Y, et al. Curr Alzheimer Res. 2021;18(6):523-532. doi: 10.2174/1567205018666211001113349. Curr Alzheimer Res. 2021. PMID: 34598664

6

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.

Jack CR Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, Knopman DS, Boeve BF, Klunk WE, Mathis CA, Petersen RC. Jack CR Jr, et al. Brain. 2008 Mar;131(Pt 3):665-80. doi: 10.1093/brain/awm336. Epub 2008 Feb 7. Brain. 2008. PMID: 18263627 Free PMC article.

7

A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.

Iaccarino L, Chiotis K, Alongi P, Almkvist O, Wall A, Cerami C, Bettinardi V, Gianolli L, Nordberg A, Perani D. Iaccarino L, et al. J Alzheimers Dis. 2017;59(2):603-614. doi: 10.3233/JAD-170158. J Alzheimers Dis. 2017. PMID: 28671117

8

Diagnostic role of 11C-Pittsburgh compound B retention patterns and glucose metabolism by fluorine-18-fluorodeoxyglucose PET/CT in amnestic and nonamnestic mild cognitive impairment patients.

Jiménez-Bonilla JF, Banzo I, De Arcocha-Torres M, Quirce R, Martínez-Rodríguez I, Lavado-Pérez C, Bravo-Ferrer Z, Rodríguez-Rodríguez E, Sánchez-Juan P, Carril JM. Jiménez-Bonilla JF, et al. Nucl Med Commun. 2016 Nov;37(11):1189-96. doi: 10.1097/MNM.0000000000000569. Nucl Med Commun. 2016. PMID: 27341411

9

Diagnostic Accuracy of Amyloid versus ¹⁸ F-Fluorodeoxyglucose Positron Emission Tomography in Autopsy-Confirmed Dementia.

Lesman-Segev OH, La Joie R, Iaccarino L, Lobach I, Rosen HJ, Seo SW, Janabi M, Baker SL, Edwards L, Pham J, Olichney J, Boxer A, Huang E, Gorno-Tempini M, DeCarli C, Hepker M, Hwang JL, Miller BL, Spina S, Grinberg LT, Seeley WW, Jagust WJ, Rabinovici GD. Lesman-Segev OH, et al. Ann Neurol. 2021 Feb;89(2):389-401. doi: 10.1002/ana.25968. Epub 2020 Dec 7. Ann Neurol. 2021. PMID: 33219525 Free PMC article.

10

Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.

Grimmer T, Wutz C, Alexopoulos P, Drzezga A, Förster S, Förstl H, Goldhardt O, Ortner M, Sorg C, Kurz A. Grimmer T, et al. J Nucl Med. 2016 Feb;57(2):204-7. doi: 10.2967/jnumed.115.163717. Epub 2015 Nov 19. J Nucl Med. 2016. PMID: 26585056 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

143 results

Results by year